Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03922555
Title ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Massachusetts General Hospital

high grade glioma


Decitabine and Cedazuridine

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST